Amid rising demand for better accuracy in administering required medications to patients, the injection pen market is finding itself impressive growth opportunities. A new study by Fact MR projects the injection pen market to reach US$ 6 Bn by the end of 2030.
Rising prevalence of various chronic ailments has been enabling growth in the injection pen market. These pens allow accurate and more convenient delivery of medication using a vial or syringe. While every person with diabetes may not need insulin, those who do find injection pens simple to use and less intrusive. Injection pens are also often used to administer medications during growth hormone therapy. Growth hormone injection treatment is sometimes prescribed to children diagnosed with turner syndrome or with deficiency of growth hormones.
For detailed insights on enhancing your product footprint, request for a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=5212
Injection Pen Market: Segmentation
Fact.MR has studied the injection pen market with detailed segmentation on the basis of by type, indication, distribution channel, and key regions.
- Growth Hormone Therapy
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than the addressee(s) is unauthorized and prohibited.”
For critical insights on this market, request for methodology here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=5212
Key Takeaways from Injection Pen Market Report
- Rising availability of insulin pens in pre-filled and durable designs has been enabling growth of the market.
- Based on type, the disposable segment is forecast to account for higher percentage of share in the injection pen market than reusable injection pens.
- In terms of indication, diabetes accounts for the maximum sales witnessed in the injection pen market.
- Retail pharmacies emerged dominant in the global market in terms of distribution channel in 2019, and expected to continue dominating through the course of the forecast period.
- Regionally, North America has been dominating the injection pen market. However, over the course of the forecast period, Asia Pacific is forecast to emerge as a more lucrative market, exhibiting a higher rate of growth.
For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/5212
Surging Demand for Insulin Pens Aiding Growth
One of the chief market drivers is the surging demand for insulin pens. These pens are rapidly replacing conventional syringes and vials on account of their user-friendly and less intrusive mechanism. Advancements introduced in quick successions also are helping the injection pen market grow.
Since an increasing number of brands have introduced insulin pens with color codes, patient pen section errors have significantly reduced. These factors are likely to play a crucial role in giving tailwinds to sales witnessed in the market.
Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2019/09/16/1915931/0/en/Sales-of-Ambulance-Cots-to-Gather-Pace-in-Line-With-Growing-Number-of-EMS-Providers-Worldwide-Fact-MR.html
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
US Sales Office:
11140 Rockville Pike
Rockville, MD 20852
Tel: +1 (628) 251-1583